RAPTIVA Side Effects

6314066-5 |
on Aug 13, 2009 Male patient from GREECE , 66 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). . Raptiva dosage: Unk. During the same period patient was treated with ANTIHYPERTENSIVES (Unk) (View Antihypertensives Review and Antihypertensives Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ).

6313849-5 | Breast Cyst, Breast Haematoma
Patient was taking Raptiva (View Usage). Patient had the following side effects: breast cyst, breast haematoma on Aug 17, 2009 from UNITED STATES Additional patient health information: Female patient , 36 years of age, weighting 125.0 lb, was diagnosed with psoriasis and. Raptiva dosage: 0.5 Ml Weekly Sq.

6288531-3 | Sepsis, Viral Infection
Adverse event was reported on Jul 22, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 125 Mg, 1/week) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 215.0 lb, After Raptiva was administered, patient had the following side effects: sepsis (What is sepsis?), viral infection (What is viral infection?).

6279254-5 | Breast Cyst, Breast Neoplasm, Neoplasm Progression
on Jul 17, 2009 Female patient from UNITED STATES , 36 years of age, weighting 130.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: breast cyst, breast neoplasm, neoplasm progression. Raptiva dosage: Weekly.


6278350-6 | Condition Aggravated, Infected Skin Ulcer, Loss Of Employment, Pain, Psoriasis, Scar, Temporal Arteritis
on Jul 20, 2009 Female patient from UNITED STATES , 63 years of age, weighting 155.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: condition aggravated, infected skin ulcer, loss of employment, pain (What is pain?), psoriasis, scar (What is scar?), temporal arteritis. Raptiva dosage: .

6273025-1 | Burning Sensation, Condition Aggravated, Depression, Pruritus, Psoriasis, Scratch, Skin Exfoliation
Patient was taking Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: burning sensation, condition aggravated, depression (What is depression?), pruritus, psoriasis, scratch, skin exfoliation on Jul 15, 2009 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 144.0 lb, was diagnosed with psoriasis and. Raptiva dosage: 50mg ? Once A Week Sq.

6261738-7 | Facial Palsy, Meningitis Aseptic
Adverse event was reported on Jul 07, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 125 Mg Q21days Sq) was diagnosed with psoriasis and. Location: UNITED STATES , 26 years of age, weighting 155.0 lb, Patient experienced the following unwanted or unexpected effects: facial palsy, meningitis aseptic. Patient was hospitalized.

6260318-7 | Alanine Aminotransferase Increased, Antibody Test Positive, Aspartate Aminotransferase, Autoimmune Hepatitis, Gamma-glutamyltransferase Increased, Hepatic Fibrosis, Hepatic Necrosis, Immunoglobulins Increased, Lymphocytic Infiltration
on Jul 01, 2009 Female patient from SWITZERLAND , 55 years of age, was treated with Raptiva (View Usage). Patient had the following side effects: alanine aminotransferase increased, antibody test positive, aspartate aminotransferase, autoimmune hepatitis, gamma-glutamyltransferase increased, hepatic fibrosis, hepatic necrosis, immunoglobulins increased, lymphocytic infiltration. Raptiva dosage: 50 Mg, 1/week.

6257716-4 | Arthritis, Dyspnoea, Feeling Hot, Progressive Multifocal Leukoencephalopathy, Psoriasis, Sinus Congestion
on Jul 01, 2009 Male patient from UNITED STATES , weighting 250.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: arthritis (What is arthritis?), dyspnoea, feeling hot, progressive multifocal leukoencephalopathy, psoriasis, sinus congestion. Raptiva dosage: 150 Unk, 1/week.

6243567-3 | Leiomyosarcoma
Patient was taking Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: leiomyosarcoma on Jun 18, 2009 from SWITZERLAND Additional patient health information: Male patient , 48 years of age, was diagnosed with psoriasis and. Raptiva dosage: 90 Mg, Unk.

6237476-3 | Hypogammaglobulinaemia
Adverse event was reported on Jun 16, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 2 Mg, 1/week) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: hypogammaglobulinaemia. During the same period patient was treated with AMBIEN (5 Mg, Qhs) (View Ambien Review and Ambien Label ), ASCORBIC ACID (Unk) (View Ascorbic Acid Review and Ascorbic Acid Label ), ULTRAVIOLET LIGHT (Unk) (View Ultraviolet Light Review and Ultraviolet Light Label ), COAL TAR + ZINC (Unk) (View Coal Tar + Zinc Review and Coal Tar + Zinc Label ).

6235267-0 | Dermatitis, Lung Infection, Pemphigoid, Respiratory Disorder
on Jun 12, 2009 Male patient from FRANCE , 82 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: dermatitis, lung infection, pemphigoid, respiratory disorder. Raptiva dosage: Unk. During the same period patient was treated with AMIODARONE (Unk) (View Amiodarone Review and Amiodarone Label ), FLUINDIONE (Unk) (View Fluindione Review and Fluindione Label ), ACETYLSALICYLATE LYSINE (Unk) (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ).

6230104-2 | Acute Febrile Neutrophilic Dermatosis, Psoriasis, Rash Erythematous
on Jun 03, 2009 Female patient from SWITZERLAND , 47 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, psoriasis, rash erythematous. Raptiva dosage: 0.7 Mg/kg, X1.

6222475-8 | Blister, Dermatitis Bullous, Pemphigoid
Patient was taking Raptiva (View Usage). Patient had the following side effects: blister, dermatitis bullous, pemphigoid on May 29, 2009 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with psoriasis and. Raptiva dosage: Unk. During the same period patient was treated with AMIODARONE HCL (Unk) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), FLUINDIONE (Unk) (View Fluindione Review and Fluindione Label ), ACETYLSALICYLATE LYSINE (Unk) (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ).

6215787-5 | Hearing Impaired, Influenza, Lung Neoplasm, Otitis Media Chronic, Pneumonia, Pneumothorax, Progressive Multifocal Leukoencephalopathy
Adverse event was reported on May 20, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 0.9 Ml, 1/week) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 190.5 lb, After Raptiva was administered, patient had the following side effects: hearing impaired, influenza, lung neoplasm, otitis media chronic, pneumonia (What is pneumonia?), pneumothorax, progressive multifocal leukoencephalopathy. Patient was hospitalized.

6209253-0 | Demyelination
on May 14, 2009 Female patient from SWITZERLAND , 65 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: demyelination. Raptiva dosage: Unk. During the same period patient was treated with REMICADE (375 Mg, X6) (View Remicade Review and Remicade Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6206454-2 | Type 1 Diabetes Mellitus
on May 27, 2009 Male patient from UNITED STATES , 56 years of age, weighting 190.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: type 1 diabetes mellitus. Raptiva dosage: 1/week Im 1.5 Years.

6204809-3 | Chills, Hepatic Enzyme Increased, Myocardial Infarction
Patient was taking Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: chills, hepatic enzyme increased, myocardial infarction on May 22, 2009 from SWITZERLAND Additional patient health information: Male patient , 75 years of age, was diagnosed with psoriasis and. Raptiva dosage: Unk.

6202346-3 | Dyspnoea, Feeling Hot, Psoriasis
Adverse event was reported on May 19, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 1.25 Ml, 1/week) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 284.9 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, feeling hot, psoriasis.

6198759-9 | Mental Disorder, Motor Dysfunction, Muscle Spasms
on May 18, 2009 Male patient from SWITZERLAND , 47 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: mental disorder, motor dysfunction, muscle spasms. Raptiva dosage: Unk.

6195643-1 | Clumsiness, Diplopia, Malaise
on May 08, 2009 Male patient from UNITED STATES , weighting 164.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: clumsiness, diplopia, malaise. Raptiva dosage: 125 Mg, 1/week.

6195480-8 | Amnesia, Hypoaesthesia
Patient was taking Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, hypoaesthesia on May 14, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with psoriasis and. Raptiva dosage: 70 Mg, 1/week. Patient was hospitalized.

6195385-2 | Actinic Keratosis, Basal Cell Carcinoma
Adverse event was reported on May 11, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 1 Mg/kg, 1/week) was diagnosed with psoriatic arthropathy, psoriasis and. Location: SWITZERLAND , 64 years of age, Patient had the following side effects: actinic keratosis, basal cell carcinoma. During the same period patient was treated with ETANERCEPT (50 Mg, 1/week) (View Etanercept Review and Etanercept Label ).

6194138-9 | Dysarthria, Headache, Memory Impairment
on May 06, 2009 Female patient from UNITED STATES , weighting 198.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: dysarthria, headache (What is headache?), memory impairment. Raptiva dosage: 0.09 Unk, 1/week. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ).

6191096-8 | Dementia, Dysphasia, Emotional Disorder, Weight Decreased
on May 13, 2009 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with abnormal loss of weight and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), dysphasia, emotional disorder, weight decreased. Raptiva dosage: Contact Dermatology; Unsure Of Dose.

6189204-8 | Muscular Weakness, Vestibular Ataxia
Patient was taking Raptiva (View Usage). Patient had the following side effects: muscular weakness, vestibular ataxia on Apr 28, 2009 from SWITZERLAND Additional patient health information: Male patient , 73 years of age, was diagnosed with psoriasis and. Raptiva dosage: 0.7 Ml, 1/week. During the same period patient was treated with UNI DIAMICRON (View Uni Diamicron Review and Uni Diamicron Label ), COSAAR PLUS (View Cosaar Plus Review and Cosaar Plus Label ). Patient was hospitalized.

6188956-0 | Convulsion, Dizziness, Psoriasis
Adverse event was reported on May 05, 2009 by a Female patient taking Raptiva (View Usage) (Dosage: Unk) was diagnosed with psoriasis and. Location: UNITED STATES , 65 years of age, After Raptiva was administered, patient had the following side effects: convulsion, dizziness (What is dizziness?), psoriasis.

6188950-X | Colitis, Colitis Ulcerative, Diarrhoea Haemorrhagic, Tachycardia
on May 04, 2009 Male patient from IRELAND , 34 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, colitis ulcerative, diarrhoea haemorrhagic, tachycardia. Raptiva dosage: 1 Mg/kg, Unk. Patient was hospitalized.

6182855-6 | Schizophrenia
on Apr 29, 2009 Male patient from SWITZERLAND , 54 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: schizophrenia. Raptiva dosage: 0.7 Mg/kg, Unk. During the same period patient was treated with DAIVOBET (Unk) (View Daivobet Review and Daivobet Label ), DAIVONEX (Unk) (View Daivonex Review and Daivonex Label ). Patient was hospitalized.

6165161-5 | Disease Complication, Headache, Myocardial Infarction, Oedema Peripheral, Product Quality Issue
Patient was taking Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: disease complication, headache (What is headache?), myocardial infarction, oedema peripheral, product quality issue on Apr 21, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 195.0 lb, was diagnosed with psoriasis and. Raptiva dosage: .9ml Once Weekly Im. Patient was hospitalized.

6160983-9 | Amnesia, Dysarthria, Migraine
Adverse event was reported on Apr 14, 2009 by a Female patient taking Raptiva (View Usage) (Dosage: Unk) was diagnosed with psoriasis and. Location: UNITED STATES , 36 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, dysarthria, migraine (What is migraine?).

6156997-5 | Colitis Ulcerative, Diarrhoea Haemorrhagic, Headache, Pyrexia, Weight Decreased
on Apr 09, 2009 Male patient from SWITZERLAND , 51 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: colitis ulcerative, diarrhoea haemorrhagic, headache (What is headache?), pyrexia, weight decreased. Raptiva dosage: Unk. During the same period patient was treated with COZAAR (1 Unk, Qd) (View Cozaar Review and Cozaar Label ), FELODIPINE (5 Mg, Qd) (View Felodipine Review and Felodipine Label ), ASPIRIN AND DIPYRIDAMOLE (Unk) (View Aspirin And Dipyridamole Review and Aspirin And Dipyridamole Label ), CITALOPRAM HYDROBROMIDE (20 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6155206-0 | Condition Aggravated, Psoriasis
on Apr 10, 2009 Male patient from UNITED STATES , 63 years of age, weighting 248.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: condition aggravated, psoriasis. Raptiva dosage: 1.1 Ml Weekly Sq.

6154751-1 | Heart Rate Increased, Psoriasis, Staphylococcal Infection
Patient was taking Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate increased, psoriasis, staphylococcal infection (What is staphylococcal infection?) on Apr 10, 2009 from SWITZERLAND Additional patient health information: Male patient , weighting 235.0 lb, was diagnosed with psoriasis and. Raptiva dosage: 113 Mg, 1/week. During the same period patient was treated with LANOXIN (0.25 Mg, Unk) (View Lanoxin Review and Lanoxin Label ), CIPROFLOXACIN (500 Mg, Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), PREDNISONE TAB (10 Mg, Unk) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6152307-8 | Lung Cancer Metastatic, Unevaluable Event
Adverse event was reported on Mar 31, 2009 by a Female patient taking Raptiva (View Usage) (Dosage: Unk) was diagnosed with acrodermatitis, therapeutic procedure and. Location: IRELAND , 72 years of age, Patient had the following side effects: lung cancer metastatic, unevaluable event. During the same period patient was treated with INFLIXIMAB (5 Mg/kg, Q8w) (View Infliximab Review and Infliximab Label ), METHOTREXATE (10 Mg, 1/week) (View Methotrexate Review and Methotrexate Label ), ETANERCEPT (50 Mg, 2/week) (View Etanercept Review and Etanercept Label ), CYCLOSPORINE (5 Mg/kg, Qd) (View Cyclosporine Review and Cyclosporine Label ), ADALIMUMAB (40 Mg, 1/week) (View Adalimumab Review and Adalimumab Label ).

6151950-X | Arthritis, Migraine
on Apr 02, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: arthritis (What is arthritis?), migraine (What is migraine?). Raptiva dosage: Unk. Patient was hospitalized.

6143406-5 | Gait Disturbance, Muscular Weakness, Myalgia
on Mar 24, 2009 Male patient from UNITED STATES , weighting 246.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, muscular weakness, myalgia. Raptiva dosage: 125 Mg, 1/week. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), METFORMIN HCL (500 Mg, Qam) (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (8 Mg, Qd) (View Aspirin Review and Aspirin Label ), FOSINOPRIL (10 Mg, Qd) (View Fosinopril Review and Fosinopril Label ), GLUCOTROL (5 Mg, Qd) (View Glucotrol Review and Glucotrol Label ), LEVITRA (Unk) (View Levitra Review and Levitra Label ).

6141980-6 | Heart Rate Increased, Psoriasis, Staphylococcal Infection
Patient was taking Raptiva (View Usage). Patient had the following side effects: heart rate increased, psoriasis, staphylococcal infection (What is staphylococcal infection?) on Mar 27, 2009 from SWITZERLAND Additional patient health information: Male patient , weighting 244.7 lb, was diagnosed with psoriasis and. Raptiva dosage: 113 Mg, 1/week. During the same period patient was treated with LANOXIN (Unk) (View Lanoxin Review and Lanoxin Label ). Patient was hospitalized.

6137378-7 | Arthritis, Migraine
Adverse event was reported on Mar 25, 2009 by a Female patient taking Raptiva (View Usage) (Dosage: Unk) was diagnosed with psoriasis and. Location: UNITED STATES , weighting 140.0 lb, After Raptiva was administered, patient had the following side effects: arthritis (What is arthritis?), migraine (What is migraine?). Patient was hospitalized.

6126089-X | Amenorrhoea
on Mar 13, 2009 Female patient from SWITZERLAND , 38 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: amenorrhoea. Raptiva dosage: 0.7 Ml, 1/week.

6123527-3 | Demyelinating Polyneuropathy
on Mar 04, 2009 Female patient from SWITZERLAND , 65 years of age, was diagnosed with arthritis (What is arthritis?) and was treated with Raptiva (View Usage). Patient had the following side effects: demyelinating polyneuropathy. Raptiva dosage: Unk. During the same period patient was treated with REMICADE (5 Mg/kg, Unk) (View Remicade Review and Remicade Label ).

6119960-6 | Amnesia, Hypoaesthesia
Patient was taking Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: amnesia, hypoaesthesia on Mar 06, 2009 from UNITED STATES Additional patient health information: Female patient , 33 years of age, . Raptiva dosage: .

6115610-3 | Abortion Spontaneous
Adverse event was reported on Mar 09, 2009 by a Female patient taking Raptiva (View Usage) (Dosage: 1 Ml, 1/week) was diagnosed with psoriasis and. Location: UNITED STATES , 40 years of age, weighting 215.0 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous. During the same period patient was treated with ANTIANXIETY AGENT NOS (View Antianxiety Agent Nos Review and Antianxiety Agent Nos Label ).

6113258-8 | Cellulitis, Limb Injury, Pertussis
on Mar 05, 2009 Male patient from SWITZERLAND , weighting 352.7 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), limb injury, pertussis. Raptiva dosage: 1 Mg/kg, 1/week. During the same period patient was treated with ACITRETIN (Unk) (View Acitretin Review and Acitretin Label ). Patient was hospitalized.

6112541-X | Septic Shock, Vomiting
on Mar 11, 2009 Male patient from UNITED STATES , 46 years of age, weighting 210.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: septic shock, vomiting. Raptiva dosage: .

6111703-5 | Balance Disorder, Gait Disturbance, Myalgia
Patient was taking Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, gait disturbance, myalgia on Feb 27, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 250.0 lb, was diagnosed with psoriasis and. Raptiva dosage: 125 Mg, 1/week. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6110422-9 | C-reactive Protein Increased, Pyrexia
Adverse event was reported on Mar 02, 2009 by a Male patient taking Raptiva (View Usage) (Dosage: 1 Mg/kg, 1/week) was diagnosed with psoriasis and. Location: SWITZERLAND , 28 years of age, Patient had the following side effects: c-reactive protein increased, pyrexia. Patient was hospitalized.

6107859-0 | Condition Aggravated, Gingival Disorder, Necrotising Ulcerative Periodontitis, Progressive Multifocal Leukoencephalopathy, Psoriasis, Resorption Bone Increased, Tooth Disorder
on Mar 05, 2009 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with psoriasis and was treated with Raptiva (View Usage). After Raptiva was administered, patient had the following side effects: condition aggravated, gingival disorder, necrotising ulcerative periodontitis, progressive multifocal leukoencephalopathy, psoriasis, resorption bone increased, tooth disorder (What is tooth disorder?). Raptiva dosage: 1 Mg / Kg Weekly Sq. During the same period patient was treated with GENGRAF (100 Mg / Day Bid Po) (View Gengraf Review and Gengraf Label ).

6107650-5 | Deafness, Psoriasis
on Mar 02, 2009 Female patient from SWITZERLAND , 51 years of age, was diagnosed with psoriasis and was treated with Raptiva (View Usage). Patient experienced the following unwanted or unexpected effects: deafness, psoriasis. Raptiva dosage: 1 Mg/kg, 1/week. During the same period patient was treated with METHOTREXATE (Unk) (View Methotrexate Review and Methotrexate Label ).

6097745-7 | Acute Febrile Neutrophilic Dermatosis, Psoriasis, Rash Erythematous
Patient was taking Raptiva (View Usage). Patient had the following side effects: acute febrile neutrophilic dermatosis, psoriasis, rash erythematous on Feb 18, 2009 from SWITZERLAND Additional patient health information: Female patient , 47 years of age, was diagnosed with psoriasis and. Raptiva dosage: Unk.